Choose Your News
The realisation of human potential for development requires age-specific investment throughout the 8000 days of childhood and adolescence. Focus on the first 1000 days is... [Read More]
Misoprostol drug Cytotec will be pulled from the French market on March 1, 2018, after reported adverse effects of off-label use. Barbara Casassus reports from... [Read More]
On Oct 28, 2017, The Lancet published the World Report "Misoprostol drug to be withdrawn from French market" as an epage.1 After further information was... [Read More]
For the past two decades, the USA has been in the throes of an opioid crisis marked by a rising number of deaths; in 2016,... [Read More]
Unlike other addictions, opioid-use disorder has several highly effective medication treatments available, in particular methadone, buprenorphine, and naltrexone.1–3 Methadone is the least accessible or acceptable... [Read More]
In this population it is more difficult to initiate patients to XR-NTX than BUP-NX, and this negatively affected overall relapse. However, once initiated, both medications... [Read More]
AIDS-related mortality in children fell by almost half between 2010 and 2016 as a result of declines in new infections and greater access to antiretroviral... [Read More]
Early mortality risk was extremely high among hospitalised HIV-infected children. Urgent ART did not improve survival. [Read More]
Colonialism leaves disfiguring scars among those who are colonised. Few countries inflicted such deep wounds as Britain did during its centuries-long colonial rule of India.... [Read More]
India is not only a large country but a diverse one. As the Director General of the Indian Council of Medical Research, Soumya Swaminathan, points... [Read More]
India's national health policy was reformed this year, but lack of accessibility and out-of-pocket expenses still leave rural areas behind. Patralekha Chatterjee reports from Uttar... [Read More]
Per capita disease burden measured as DALY rate has dropped by about a third in India over the past 26 years. However, the magnitude and... [Read More]
The landmark CANTOS trial evaluated the use of canakinumab, a monoclonal antibody targeting interleukin 1β, in 10 061 patients with previous myocardial infarction who had high-sensitivity... [Read More]
The magnitude of hsCRP reduction following a single dose of canakinumab might provide a simple clinical method to identify individuals most likely to accrue the... [Read More]
The social gradient in health describes a graded association between an individual's position on the social hierarchy and health: the lower the socioeconomic position of... [Read More]
Inclusion health is a service, research, and policy agenda that aims to prevent and redress health and social inequities among the most vulnerable and excluded... [Read More]
Our study shows that homeless populations, individuals with substance use disorders, sex workers, and imprisoned individuals experience extreme health inequities across a wide range of... [Read More]
Viral hepatitis caused an estimated 1·4 million deaths in 2015—similar to tuberculosis and more than either HIV or malaria, yet historically these diseases have received... [Read More]
Pneumonia kills almost 1 million children each year, and more than 80% of these deaths are children under 2 years of age. While not solely... [Read More]
On Nov 8, a high-level panel—Health for All: #Walktogether—was held in New York City, NY, USA. It brought together two Elders—former Secretary General of the... [Read More]
Elsevier Popular Tags
Advanced-Stage Hodgkin's Lymphoma - Africa3 Mortality - Antiretroviral Therapy - Art)1 Art - Barbara Casassus - Case Report - Climate Change - Colonialism Leaves Disfiguring Scars - Colonised Few Countries Inflicted Such Deep Wounds - Comment Extended - Comment Inclusion - Comment Medications - Comment Offline - Comment Retraction - Comment Timing - Comment Treatment - Correspondence Diet - Development Requires Age-Specific Investment Throughout - Disease Control - Disease Study - Drug Administration - Early Mortality Risk - Editorial India—a - Effective Future Work - Extended-Release Naltrexone Injection - Facilitating Induction - French Market - Gestational Age - Global Burden - Health Research Center Aphrc - High-Sensitivity C-Reactive Protein - Improving Treatment Retention - Inclusion Health - India State-Level Disease Burden - India Understanding - Initiate Patients - Kenya Push - Lancet Countdown - Lancet Editors - Lancet Infectious Diseases - Larger Community Additionally - Medical Research Soumya Swaminathan - Misoprostol Drug - Naltrexone1–3 Methadone - Nation's Estimated 64 000 Fatal Drug Overdoses1 - National Institution - Negatively Affected Overall Relapse However - Neonatal Abstinence Syndrome - New York City NY USA - Not Improve Survival - Patralekha Chatterjee - Public Health - Review Investment - Review What - Several Highly Effective Medication Treatments Available - Sex Workers - Sustainable Development Goals SDGS - Transforming India - Type 2 Diabetes - Unlike Other Addictions - Urgent Art - Uttar Pradesh - When Substantial Changes Place Commensurate Demands - Which Exposed Pain Patients - World Health Assembly - World Report Misoprostol